Publicerat: 2026-01-13 08:14:43
Detta är en nyhet från nyhetsbyrån Finwire Disclaimer
The cannabis company Dancann Pharma, which is aiming for a delisting, states that no warrants were exercised during the additional exercise period that followed the company's application for delisting from Spotlight. The period ran between 29 December and 12 January. A total of 1,224,993 warrants have therefore expired and are no longer outstanding. Dancann Pharma's last trading day on Spotlight Stock Market is 22 January.
Läs mer om DanCann Pharma A/S